Document is current
Any future updates will be listed below
-
Authors
Nelson, Leonela
Lopez, Laura Mata
Archuleta, Shannon
Van Wyk, Stephanie Skavenski
Kushman, Elizabeth
Martin, Lisa
Mitchell, Kristin
Leffler, Elizabeth
Werwie, Timothy R.
Kemp, Christopher G.
Cuddy, Reese F.
Haroz, Emily E.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse of the National Institutes of Health (R01DA057913)
National Institute on Drug Abuse of the National Institutes of Health (R01DA057913)
National Institute on Drug Abuse of the National Institutes of Health (R01DA057913)
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 5 February 2026
First Online: 26 February 2026
Declarations
:
: This study was reviewed and approved by the Health Board and Agency Councils in the participating Navajo communities. This study also received community support from the Pokagon Band of Potowatami. This study was reviewed and approved by the Navajo Nation Human Subjects Research Review Board (NNHRRB ## NNR-23.463), and the Johns Hopkins Bloomberg School of Public Health Institutional Review Board (Current protocol version: #23017). Any protocol modifications are submitted as an amendment to relevant IRBs. Supervisors then inform study staff and conduct additional training as needed. If protocol modifications are significant, trial registries are updated. The study is overseen by Community Advisory Boards (CAB) and a Data Safety and Monitoring Board (DSMB).
: Not applicable.
: The authors declare no competing interests.
